gross

Revive Therapeutics Announces Closing of Second Tranche of Private Placement

TORONTO, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a…

7 days ago

Enovix Announces Completion of Warrant Dividend Program

September 05, 2025 18:08 ET  | Source: Enovix Corporation Warrants Expired and Ceased Trading on Friday, August 29, 2025 Approximately…

3 weeks ago

DBV Technologies Establishes an At-The-Market (ATM) Program on Nasdaq

Châtillon, France, September 5, 2025 DBV Technologies Establishes an At-The-Market (ATM) Program on Nasdaq DBV Technologies (Euronext: DBV – ISIN:…

3 weeks ago

Angelalign Technology Announces First-Half 2025 Results While Increasing Investments in Legal, Supply Chain and Data Security

SAN CLEMENTE, Calif., Aug. 26, 2025 /PRNewswire/ -- Angelalign Technology Inc. ("Angel" or the "Company") (6699.HK) announced its interim results…

4 weeks ago

Venus Concept Announces Closing of Up To $3.45 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

TORONTO, June 09, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical…

4 months ago

Xilio Therapeutics Announces Closing of $50.0 Million Public Offering

June 05, 2025 18:38 ET  | Source: Xilio Therapeutics, Inc. Total gross proceeds of up to $150.0 million before the…

4 months ago